Michael Kitt is President & VP at THERAVANCE INC (THRX). They have made 4 open-market trades across 1 company since 2006, most recently 2008-06-04.
CIK 0001302447
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| THRX | 45,738 | $186K |
Shares reported on the most recent Form 4, priced at the 2008-06-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| THRX | SELL | 2008-06-02 | 2008-06-04 | $13.01 | $259K | -6.0% | -1.1% | -1.1% |
| THRX | SELL · 10b5-1 | 2007-08-23 | 2007-08-24 | $30.00 | $300K | -6.0% | -1.1% | -1.1% |
| THRX | SELL | 2006-06-09 | 2006-06-13 | $24.08 | $115K | -6.0% | -1.1% | -1.1% |
| THRX | SELL | 2006-06-09 | 2006-06-13 | $24.00 | $27K | -6.0% | -1.1% | -1.1% |
| THRX | SELL | 2006-06-09 | 2006-06-13 | $24.17 | $169K | -6.0% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.